Logo
Contact Us
Banner

Solutions

Pancreatic Cancer Basic Research Services

Alfa Cytology is a leading custom service provider with experience in pancreatic cancer (PC) basic research. We are now proud to offer a full range of PC basic research services, such as PC cell research, PC stem cell (CSC) research, PC genetic/molecular research, PC biomarker discovery and analysis, PC model services, and so on. Based on robust platforms, powerful analytics, cross-platform collaborations, and years of experience in the PC field, we are committed to providing our customers with optimal customized services to meet their needs for PC basic research.

Learn More
Pancreatic Cancer Basic Research Service
Pancreatic Cancer Drug Development Services

Pancreatic Cancer Drug Development Services

As the scientific machine continues to turn, Alfa Cytology is committed to keeping pace. We continue to expand our services and improve our existing resources to help our customers accelerate their research and support their careers. We are committed to providing a range of PC drug development services to our global clients ranging from pharmaceutical, biotechnology, and research institutions.

Small Molecule Drug Development

for Pancreatic Cancer

Peptide Drug Development

for Pancreatic Cancer

Antibody Drug Development

for Pancreatic Cancer

Nucleic Acid Drug Development

for Pancreatic Cancer

Oncolytic Viral Therapy Development

for Pancreatic Cancer

Pancreatic Cancer Vaccine Development Services

Whole-Cancer Cell Vaccine

Development for Pancreatic Cancer

Whole cancer cell-based vaccines use irradiated and modified cancer cells as immunogens and may trigger a robust immune response and an enhanced anti-tumor response.

Peptide-Based Vaccine

Development for Pancreatic Cancer

Peptide-based cancer vaccines typically consist of amino acids that contain specific epitopes of antigens known to be highly immunogenic, thereby triggering the desired immune response.

Custom mRNA Vaccine

Development for Pancreatic Cancer

mRNA vaccines consist of one or more nucleic acids that encode single or multiple vaccine antigen candidates, directly transported into the host cell via customized delivery vectors.

Pancreatic Cancer

Pancreatic Cancer Diagnostic Development Services

Pancreatic Cancer Basic Research Service

Alfa Cytology is a leading custom service provider with experience in pancreatic cancer (PC) basic research and drug development. We are also committed to helping our customers develop successful PC diagnostic biomarkers through tailored services, robust platforms, powerful analytics, and cross-platform collaborations. We are proud to offer a full range of PC diagnostic development services, involving protein biomarkers, miRNAs, circulating exosomes, circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and metabolites, and microbiota.

  • Protein diagnostic biomarker development for PC
  • miRNAs as diagnostic biomarkers for PC
  • Circulating exosomes as diagnostic biomarkers for PC
  • CTCs as diagnostic biomarkers for PC
  • ctDNAs as diagnostic biomarkers for PC
  • Metabolites as diagnostic biomarkers for PC
  • Microbiota as diagnostic biomarkers for PC
Learn More
All of our services are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Logo

As the scientific machine continues to turn, Alfa Cytology is committed to keeping pace. We continue to expand our services and improve our existing resources to help our customers accelerate their research and support their careers.

Company
Our Services
Our Products

Copyright © Alfa Cytology. All rights reserved.